|
⚲
|
| Keyboard |
| Kinderhook Partners LLC
✚
|
|
|---|---|
| CRD # | 156983 |
| SEC # | 801-72492 |
| CIK # | 0001542439, 0001220338 |
| AUM | |
| Employees | 4 (75% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 201-461-0955 |
| Address | 2 Executive Drive Fort Lee, NJ 07024 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/31/2015) [Brochure] |
|---|
Fees
and
Compensation
Management
Fees
Kinderhook's
fees
are
fixed
and
based
on
a
percentage
of
assets
under
management.
Management
fees
are
not
negotiable,
charged
quarterly
in
advance
at
the
beginning
of
each
quarter,
and
deducted
directly
from
client
assets.
Management
fees
are
pro-‐
rated
for
each
capital
contribution
and
withdrawal
made
during
the
applicable
calendar
quarter.
If
a
client
account
is
initiated
or
terminated
during
a
calendar
quarter
it
will
be
charged
a
prorated
fee.
The
amount
of
any
refund
will
be
calculated
by
dividing
the
most
recent
management
fee
by
the
number
of
days
in
the
quarter
and
multiplying
that
figure
by
the
number
of
days
left
in
the
quarter
following
the
date
of
termination.
The
management
fee
is
charged
as
follows:
Client
Account
Value
Annual
Fee
From
To
(charged
and
payable
quarterly)
$0
$150,000,000
2.0%
$150,000,001
$250,000,000
1.5%
Greater
than
$250,000,000
1.0%
Other
Fees
Management
fees
are
exclusive
of
brokerage
commissions
and
transaction
fees.
Clients
may
incur
other
charges
imposed
by
custodians,
brokers,
and
other
third
parties
such
as
custodial
fees,
deferred
sales
charges,
odd-‐lot
differential
fees,
transfer
taxes,
wire
transfer
and
electronic
fund
transfer
fees,
and
other
fees
and
taxes
on
brokerage
accounts
and
securities
transactions.
Mutual
funds
and
exchange
traded
funds
also
charge
internal
management
fees,
which
are
disclosed
in
a
fund’s
prospectus.
Such
charges,
fees
and
commissions
are
exclusive
of
and
in
addition
to
Kinderhook's
management
fee.
Kinderhook
and
its
partners,
officers,
and
employees
sometimes
become
board
members
of
portfolio
companies
and
for
their
participation
generally
receive
director
fees
in
the
form
of
cash
and
equity-‐based
compensation.
Kinderhook,
in
its
sole
discretion,
may
offset
its
management
fee
in
an
amount
equal
to
the
value
of
any
compensation
received
from
such
activity.
The
“Selecting
Brokerage
Firms”
section
below
describes
circumstances
under
which
Kinderhook
receives
research
and
other
benefits
from
brokers
with
whom
Kinderhook
executes
trades. |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2015) [Brochure] |
|---|
Types
of
Clients
Description
Kinderhook
provides
investment
advice
to
pooled
investment
vehicles.
Account
Minimums
Kinderhook
does
not
impose
minimum
account
size
requirements
on
clients.
Methods
of
Analysis,
Investment
Strategies
and
Risk
of
Loss
Description
Kinderhook
believes
that
there
are
opportunities
to
purchase
ownership
positions
in
businesses
at
the
small
end
of
the
publicly
traded
company
spectrum.
These
companies
have
values
that
are
likely
to
grow
rapidly,
but
which
are
priced
low
enough
that
the
risk
of
substantial
loss
of
capital
is
modest.
Consequently,
Kinderhook
primarily
makes
long-‐term
equity
investments
in
domestic
and
foreign
small
and
micro
capitalization
public
companies
and
to
a
lesser
extent
private
companies,
but
may
also
invest
in
other
types
of
securities.
When
making
investments,
Kinderhook
seeks
to
take
positions
in
companies
that
will
generate
a
target
return
of
three
to
five
times
the
cost
of
investment
over
a
three
to
five
year
period. |
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Kinderhook LP | 2012-03-30 | 195.3 M |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 1 | 195.3 |
| By Discretionary | ||
| Discretionary | 1 | 195.3 |
| Non-Discretionary | 0 | 0.0 |
| Total | 1 | 195.3 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 195.3 | |
| Total | 1 | 195.3 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001220338] | |
| 4 | [0001220338] | |
| SC 13D | [0001220338] | |
| SC 13G | [0001220338] | |
| 3 | [0001542439] | |
| 4 | [0001542439] | |
| SC 13D | [0001542439] | |
| SC 13G | [0001542439] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Patient Safety Technologies Inc PSTX.OB
Common Stock, par value $0.0001
|
2014-01-24 | Sell | 49,500 | $2.20 | 108,900 |
|
Patient Safety Technologies Inc PSTX.OB
Common Stock, par value $0.0001
|
2014-01-23 | Sell | 737,625 | $2.20 | 1,622,775 |
|
Patient Safety Technologies Inc PSTX.OB
Common Stock, par value $0.0001
|
2014-01-22 | Sell | 2,170,139 | $2.20 | 4,774,306 |
|
Patient Safety Technologies Inc PSTX.OB
Common Stock, par value $0.0001
|
2014-01-16 | Sell | 1,302,000 | $2.20 | 2,864,400 |
|
Patient Safety Technologies Inc PSTX.OB
Common Stock, par value $0.0001
|
2014-01-14 | Sell | 240,334 | $2.20 | 528,735 |
|
Patient Safety Technologies Inc PSTX
Common Stock, par value $0.0001
|
2014-01-10 | Sell | 50,000 | $2.20 | 110,000 |
|
Patient Safety Technologies Inc PSTX
Common Stock, par value $0.0001
|
2014-01-09 | Sell | 1,849,918 | $2.20 | 4,069,820 |
|
Planet Payment Inc PLPM
Common Stock, par value $0.01
|
2014-01-03 | Sell | 50,000 | $2.97 | 148,500 |
|
Liberator Medical Holdings Inc LBMH
Warrant (right to buy) · derivative
|
2013-02-14 | Grant | 45,000 | $0.00 | |
|
Coastal Contacts Inc COA
Common Stock, no par value
|
2012-11-28 | Sell | 250,000 | $5.53 | 1,382,500 |
|
Neogenomics Inc NGNM
Common Stock, par value $0.001
|
2012-06-20 | Buy | 67,437 | $1.70 | 114,643 |
|
Neogenomics Inc NGNM
Common Stock, par value $0.001
|
2012-06-19 | Buy | 5,000 | $1.65 | 8,250 |
|
Neogenomics Inc NGNM
Common Stock, par value $0.001
|
2012-06-18 | Buy | 11,600 | $1.64 | 19,024 |
|
Patient Safety Technologies Inc PSTX.OB
Common Stock
|
2012-05-18 | Buy | 1,045,642 | $1.40 | 1,463,899 |
|
Neogenomics Inc NGNM
Common Stock, par value $0.001
|
2012-05-17 | Buy | 100,000 | $1.70 | 170,000 |
|
Neogenomics Inc NGNM
Common Stock, par value $0.001
|
2012-05-15 | Buy | 175,000 | $1.70 | 297,500 |
|
Active Power Inc ACPW
Common Stock
|
2012-03-07 | Buy | 8,823,529 | $0.68 | 6,000,000 |
|
Patient Safety Technologies Inc PSTX.OB
Common Stock
|
2012-02-21 | Buy | 10,000 | $1.05 | 10,500 |
|
Patient Safety Technologies Inc PSTX.OB
Common Stock
|
2012-02-17 | Buy | 37,127 | $1.05 | 38,983 |